<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04613830</url>
  </required_header>
  <id_info>
    <org_study_id>515</org_study_id>
    <nct_id>NCT04613830</nct_id>
  </id_info>
  <brief_title>Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients</brief_title>
  <official_title>Continuous Erector Spinae Plane Local Anesthetic Infusion for Postoperative Analgesia in Pediatric Patients Undergoing Nephrectomy: Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the analgesic efficacy of erector spinae plane block in&#xD;
      pediatric cancer patients undergoing open nephrectomy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Sixty patients will be included in this prospective randomized study. The patients will&#xD;
           be allocated into two groups: the ESPB group (group E, n = 30) and the tramal group&#xD;
           (group T, n =30).&#xD;
&#xD;
        -  All patients will receive standard general anesthesia. Ultrasound-guided ESPB will be&#xD;
           performed to group erector spinae plane block&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 20, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>total amount of opioid consumption in milligram</measure>
    <time_frame>48 hours</time_frame>
    <description>total amount of opioid consumption in the frist 48hours postoperative</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pediatric Cancer</condition>
  <arm_group>
    <arm_group_label>Erector spinae group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patient will be placed in a sitting position under complete aseptic condition and a cover sheath will be used for the ultrasound probe with an appropriate amount of lubricating gel applied on the probe, a high-frequency linear ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the T7 spinous process. This should reveal three muscles superficial to the hyperechoic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Opioid GROUP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patient in group T will intravenously administrate dose of 1 mg/kg/8hr tramal ( opioid) to be increased upon patient needs up to 2mg/kg/6hr as rescue analgesic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride</intervention_name>
    <description>The patient will be placed in a sitting position under complete aseptic condition and a cover sheath will be used for the ultrasound probe with an appropriate amount of lubricating gel applied on the probe, a high-frequency linear ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the T7 spinous process. This should reveal three muscles superficial to the hyperechoic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae. then injecte bupivacaine hydrochloride</description>
    <arm_group_label>Erector spinae group</arm_group_label>
    <other_name>erector spinae block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tramadol hydrochloride</intervention_name>
    <description>Patients in group Tramadol will intravenously administrate dose of 1 mg/kg/8hr tramal to be increased upon patient needs up to 2mg/kg/6hr as rescue analgesic</description>
    <arm_group_label>Opioid GROUP</arm_group_label>
    <other_name>opioid group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Physical status ASA II.&#xD;
&#xD;
          -  Patients (age 2-7yrs) scheduled for open nephrectomy for malignant kidney tumors&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of psychological disorders.&#xD;
&#xD;
               -  Known sensitivity or contraindication to local anesthetics.&#xD;
&#xD;
               -  Localized infection at the site of block.&#xD;
&#xD;
               -  patients with coagulopathy or an (INR â‰¥ 2)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>fatma el sherif, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>fatma el sherif, MD</last_name>
    <phone>01005887717</phone>
    <email>fatma_anesthesia@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>South Egypt Cancer instIitute</name>
      <address>
        <city>Assuit</city>
        <zip>171516</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>fatma ad el sherif, lecturer</last_name>
      <phone>088233018</phone>
      <email>fatma_anesthesia@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 23, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>November 23, 2020</last_update_submitted>
  <last_update_submitted_qc>November 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Fatma Adel El sherif,MD</investigator_full_name>
    <investigator_title>Associated professor of anesthesia,ICU and pain management</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tramadol</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

